Bavarian Nordic Beats Q3 Revenue Expectations
Bavarian Nordic posted third quarter revenue of 1.81 billion Danish crowns, beating analyst estimates. The growth was driven by strong demand in its travel health business.
Xurve View
Insights:
Xurve View
BAVARIAN NORDIC A/S posted third-quarter revenue of 1.81 billion Danish crowns ($267.81 million) on Friday morning, beating analyst consensus expectations of 1.69 billion. The Danish vaccine maker's performance was driven by a continued surge in travel health product sales. The beat underscores robust demand for travel-related immunizations, offsetting volatility in the preparedness-vaccine segment.
